Stock Earnings

Question 1

Recursion Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Recursion Pharmaceuticals Incの総資産は$1,448で、純lossは$-463です。

Question 2

RXRXの主要な財務比率は何ですか？

Accepted Answer

Recursion Pharmaceuticals Incの流動比率は3.5、純利益率は-798.27、1株当たり売上高は$0.21です。

Question 3

Recursion Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Recursion Pharmaceuticals Inc largest revenue segment is Drug Discovery, at a revenue of 58,839,000 in the most earnings release.For geography, United States is the primary market for Recursion Pharmaceuticals Inc, at a revenue of 58,839,000.

Question 4

Recursion Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Recursion Pharmaceuticals Incの純lossは$-463です。

Question 5

Recursion Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、Recursion Pharmaceuticals Incの負債は413です。

Question 6

Recursion Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

Recursion Pharmaceuticals Incの総発行済株式数は396.5株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	64	58	44	39	10	3
Revenue Growth (YoY)	31%	32%	13%	290%	233%	50%
Cost of Revenue	66	45	42	48	--	--
Gross Profit	-2	13	1	-8	--	--
Selling, General & Admin	216	178	133	95	66	27
Research & Development	419	295	208	141	125	61
Operating Expenses	647	492	350	237	192	88
Other Non Operating Income (Expenses)	-7	0	-1	0	0	0
Pretax Income	-649	-464	-332	-239	-186	-87
Income Tax Expense	0	-1	-4	--	--	--
Net Income	-649	-463	-328	-239	-186	-87
Net Income Growth	74%	41%	37%	28%	113.99%	43%
Shares Outstanding (Diluted)	417.36	274.2	207.85	175.54	125.35	162.16
Shares Change (YoY)	72%	32%	18%	40%	-23%	0%
EPS (Diluted)	-1.55	-1.69	-1.57	-1.36	-1.49	-0.54
EPS Growth	1%	7%	16%	-9%	176%	42%
Free Cash Flow	-393	-372	-299	-120	-198	-51
Free Cash Flow Per Share	-0.94	-1.35	-1.43	-0.68	-1.57	-0.31
Gross Margin	-3.12%	22.41%	2.27%	-20.51%	--	--
Operating Margin	-1,014.06%	-825.86%	-790.9%	-628.2%	-1,820%	-2,800%
Profit Margin	-1,014.06%	-798.27%	-745.45%	-612.82%	-1,860%	-2,900%
Free Cash Flow Margin	-614.06%	-641.37%	-679.54%	-307.69%	-1,980%	-1,700%
EBITDA	-586	-443	-324	-234	-174	-80
EBITDA Margin	-915.62%	-763.79%	-736.36%	-600%	-1,739.99%	-2,666.66%
D&A For EBITDA	63	36	24	11	8	4
EBIT	-649	-479	-348	-245	-182	-84
EBIT Margin	-1,014.06%	-825.86%	-790.9%	-628.2%	-1,820%	-2,800%
Effective Tax Rate	0%	0.21%	1.2%	--	--	--

Recursion Pharmaceuticals Inc (RXRX) Price

RXRX Stock Price Chart

RXRX Income

Follow-Up Questions